Skip to content
DefDex

Federal award

FULGENT THERAPEUTICS LLC

70FB7020P00000068

Contract

Obligated and Ceiling

Obligated (net)
$1,728,891.42
Ceiling (potential value, not spending)
$2,658,424.66
Current value
$1,728,891.42
Gross positive obligations
$1,888,511.16

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
FULGENT THERAPEUTICS LLC · JVZDRESJLD82
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FULGENT GENETICS, INC. · Y9JMAEN8GRK6
Awarding agency
Department of Homeland Security · sub-agency 7022 · office 70FB70
Funding agency
Department of Homeland Security · sub-agency 7022
Product or service (PSC)
Q403 · MEDICAL- EVALUATION/SCREENING
Industry (NAICS)
621511 · MEDICAL LABORATORIES
PIID
70FB7020P00000068
Award type code
B
Actions
9 · Sep 17, 2020 to May 5, 2022
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History9

Award actions
DateFYModAction typeObligationCompany in company totals
May 5, 2022FY2022P00008K−$159,619.74
—
Sep 15, 2021FY2021P00007B$0.00
—
Jun 14, 2021FY2021P00006G$0.00
—
May 14, 2021FY2021P00005B$455,544.40
—
Mar 17, 2021FY2021P00004G$0.00
—
Nov 13, 2020FY2021P00003B$0.00
—
Nov 9, 2020FY2021P00002B$13,208.40
—
Oct 30, 2020FY2021P00001B$2,258.36
—
Sep 17, 2020FY20200—$1,417,500.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.